This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: **Innovator Spotlight: Xuejun Jin**
Introduction
Xuejun Jin is a notable inventor based in Taejeon-si, South Korea. He is recognized for his contributions to the field of biotechnology, particularly in developing innovative compounds that target critical health issues.
Latest Patents
Xuejun Jin holds a patent for "Compounds that inhibit HIF-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component." This invention reveals an HIF-1 inhibitor that demonstrates anticancer properties by effectively inhibiting HIF-1, a transcription factor integral to cancer growth and metastasis. The patent highlights that the HIF-1 inhibitor is not generally cytotoxic, making it a potential therapeutic solution for various cancers, including liver, stomach, and breast cancer. Additionally, the compounds developed by Jin may also be utilized in treating diabetic retinopathy and arthritis, conditions exacerbated by HIF-1-mediated VEGF expression.
Career Highlights
Xuejun Jin is associated with the Korea Research Institute of Bioscience and Biotechnology, where he has honed his expertise in pharmaceutical compositions and their implications in modern medicine. His work has significant implications for cancer treatment and showcases his dedication to addressing pressing health challenges through innovative solutions.
Collaborations
Throughout his career, Xuejun Jin has collaborated with various professionals, including colleagues Jung Joon Lee and Jeong-Hyung Lee. These collaborations have likely fostered an environment of innovation, enabling Jin to push the boundaries of current biotechnology practices.
Conclusion
Xuejun Jin's contributions to the field of biopharmaceuticals mark him as a significant inventor in the ongoing fight against cancer and related diseases. His patent serves as a testament to his innovative approach and the potential impact of his work on healthcare. As he continues to explore new avenues in research, the scientific community looks forward to the benefits his inventions will bring.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile